| (210) | Number of the EPO application | 17728484 |
| (220) | Filing date of the EPO application | 2017.05.30 |
| (80) | EPO patent specification publication (B) | EPB nr. 17/2021, 2021.04.28 |
| (110) | EPO patent number | 3465214 |
| (11) | Number of the document | MD 3465214 T2 |
| (21) | Number of the application | e 2019 0405 |
| (71) | Name(s) of applicant(s), code of the country | MORPHOSYS AG, DE; |
| (72) | Name(s) of inventor(s), code of the country | ENDELL Jan, DE;
WINDERLICH Mark, DE;
BOXHAMMER Rainer, DE; |
| (73) | Name(s) of owner(s), code of the country | MORPHOSYS AG, DE; |
| (54) | Title of the invention | Methods for predicting therapeutic benefit of anti-cd19 therapy in patients |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | G01N 33/574 (2006.01.01) |
| (19) | Country | DE |
| (41) | Date of publication of the application | 2019.05.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2021.09.30 |
| (30) | Priority | 16171885, 2016.05.30, EP |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/EP2017/063045, 2017.05.30 |
| (87) | International publication | WO 2017/207574, 2017.12.07 |